Sovaldi, a once-a-day prescription medicine used to treat hepatitis C. Manufacturer Gilead Sciences is working out how to bring the drug, which infamously retails in the US at $1,000 a pill, for relatively next to nothing to low income countries around the world.

Gregg Alton has what seems like a disorienting job at Gilead Sciences. He’s paid to figure out how to sell the drug Sovaldi, which infamously re(...)

Irish International has retained the Road Safety Authority (RSA) creative account with MediaVest retaining the media side of the business. It followed(...)